Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000031.xml
Klin Monbl Augenheilkd 2024; 241(04): 498-499
DOI: 10.1055/a-2282-3278
DOI: 10.1055/a-2282-3278
Kasuistik
Iatrogenic Macular Hemorrhage after Dexamethasone Implant Injection
Iatrogene Makulablutung nach Injektion eines Dexamethason-Implantats
Purpose
We present a case of iatrogenic macular hemorrhage associated with an internal limiting membrane (ILM) rupture following intravitreal injection of a dexamethasone implant (0.7 mg Ozurdex: 6 mm long, 0.46 mm diameter, 0.0012 g).
Publication History
Received: 26 December 2023
Accepted: 29 February 2024
Article published online:
23 April 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Casati S, Bruni E, Marchini G. Retinal and vitreous hemorrhage after traumatic impact of dexamethasone implant in a vitrectomized eye. Eur J Ophthalmol 2016; 26: e55-e57 DOI: 10.5301/ejo.5000716.
- 2 Elliott MS, Montezuma SR. Retina Injury After Dexamethasone Injection Into a Vitrectomized Eye. J Vitreoretin Dis 2020; 4: 538-540 DOI: 10.1177/2474126420934238.
- 3 Meyer CH, Klein A, Alten F. et al. Release and velocity of micronized dexamethasone implants with an intravitreal drug delivery system: kinematic analysis with a high-speed camera. Retina 2012; 32: 2133-2140 DOI: 10.1097/IAE.0b013e31825699e5.
- 4 Bastakis GG, Dimopoulos D, Stavrakakis A. et al. Long-term efficacy and duration of action of dexamethasone implant, in vitrectomised and non-vitrectomised eyes with persistent diabetic macular oedema. Eye (Lond) 2019; 33: 411-418 DOI: 10.1038/s41433-018-0219-8.